Publikationen, an denen er mitarbeitet Luisa Maria Seoane Camino (14)

2022

  1. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

2021

  1. Circulating LEAP-2 is associated with puberty in girls

    International Journal of Obesity, Vol. 45, Núm. 3, pp. 502-514

2019

  1. ANGPTL-4 is associated with obesity and lipid profile in children and adolescents

    Nutrients, Vol. 11, Núm. 6

2018

  1. 25-Hydroxyvitamin D levels of children are inversely related to adiposity assessed by body mass index

    Journal of Physiology and Biochemistry, Vol. 74, Núm. 1, pp. 111-118

  2. Circulating Pro-Uroguanylin Levels In Children And Their Relation To Obesity, Sex And Puberty

    Scientific Reports, Vol. 8, Núm. 1

  3. Plasma ANGPTL-4 is Associated with Obesity and Glucose Tolerance: Cross-Sectional and Longitudinal Findings

    Molecular Nutrition and Food Research, Vol. 62, Núm. 10

2017

  1. Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway

    World Journal of Gastroenterology, Vol. 23, Núm. 35, pp. 6403-6411

2016

  1. FNDC5 is produced in the stomach and associated to body composition

    Scientific Reports, Vol. 6

  2. Regulation of Growth Hormone by the Splanchnic Area

    Progress in Molecular Biology and Translational Science (Elsevier B.V.), pp. 41-60

  3. Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner

    European Journal of Nutrition, Vol. 55, Núm. 2, pp. 529-536

2015

  1. Peripheral signals mediate the beneficial effects of gastric surgery in obesity

    Gastroenterology Research and Practice, Vol. 2015

  2. Regulation of NUCB2/nesfatin-1 production in rat's stomach and adipose tissue is dependent on age, testosterone levels and lactating status

    Molecular and Cellular Endocrinology, Vol. 411, pp. 105-112

2014

  1. Drug development strategies for the treatment of obesity: How to ensure efficacy, safety, and sustainable weight loss

    Drug Design, Development and Therapy, Vol. 8, pp. 2391-2400

2013

  1. The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake

    PLoS ONE, Vol. 8, Núm. 11